One year after the launch of the international network of BIOCATALYSIS, Olon has achieved the developing a new production process through engineering target enzyme
Our Spanish manufacturing site, Derivados Quimicos, was inspected by Servicio de Ordenacion y Atencion Farmaceutica
Regulatory Approvals: the DMF of UMECLIDINIUM BROMIDE has been submitted to FDA under GDUFA procedure